Red List

ARVNArvinas, Inc.

Healthcare · Biotechnology · small-cap ($587M)
-43.0%
from rolling 252-day high of $14.51 set 2026-03-10 · 122d ago
Current
$8.27
Decline depth
-43.0%
Decline σ
3.6σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$ARVN landed on the list 2026-03-02, down 29.3% from its 52-week high that day — now down -43.0%.

That's 28.4 percentage points deeper than the day it joined. It bottomed 63.1% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

ARVN qualifies for the Red List on decline depth.

Decline depth
-43.0%
From rolling 252-day high of $14.51, 122d ago. Past the 40% Red List threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
3.6σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (2.42% per day).

The structural read

What price action says about ARVN.

ARVN qualifies for the Red List on decline depth — down -43.0% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 3/5 bearish time frames.

Earnings on file: 2026-05-12. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $6.06 26.2% of range 52W high $14.51

Sector context · Healthcare

132 other Healthcare tickers are on Broken Stocks.

61 Red List
34 Amber
37 Watch
-36.1% Median decline

Worst in sector: UPB (-77.6%). Least-bad: ENTA (-20.1%). See all Healthcare listings →

Questions about ARVN

What people ask.

Why is ARVN on Broken Stocks?

ARVN qualifies for the Red List on decline depth. It is down -43.0% from its rolling 252-day high of $14.51, set on 2026-03-10 — 122d ago.

Is ARVN a falling knife?

Not by the strict technical definition. ARVN is down -43.0% from its 52-week high, but that high was set 122d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ARVN is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is ARVN a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is ARVN trading inside its 52-week range?

At $8.27, ARVN sits 26.2% of the way from its 52-week low ($6.06) to its 52-week high ($14.51). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has ARVN been declining?

The current 43.0% decline accrued over 122d, which annualizes to roughly -128.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does ARVN compare to its sector?

There are 132 other Healthcare tickers on Broken Stocks: 61 Red, 34 Amber, 37 Watch, with 46 showing recovering structural signals. Median sector decline is -36.1% — ARVN's decline is deeper than the sector median.

Does ARVN's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-12) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.